| Date | Title | Description |
| 12.08.2026 | Vedanta Biosciences Secures $60M for Groundbreaking Microbiome Therapy | Vedanta Biosciences secured $60 million in new capital. The Cambridge, MA biopharma advances microbiome-based oral therapies. Funds fuel its pivotal Phase 3 RESTORATiVE303 study. This trial targets recurrent C. difficile infection. Investor... |
| 06.08.2026 | Vedanta Biosciences Raises $60M in Funding | Vedanta Biosciences, a Cambridge, MA-based provider of microbiome-based oral therapies for gastrointestinal diseases, raised $60M in funding.
The round was led by AMR Action Fund and BNP Paribas Asset Management Alts, with participation fro... |
| 06.08.2026 | ReCode Therapeutics Receives Investment From Cystic Fibrosis Foundation | ReCode Therapeutics, a Menlo Park, CA-based clinical-stage genetic medicines company, received an investment from Cystic Fibrosis Foundation (CF Foundation).
The amount of the deal was not disclosed.
The company intends to use the funds to ... |
| 29.09.2025 | ReCode Therapeutics Raises Over $29M in Additional Financing | ReCode Therapeutics, a Menlo Park, CA-based clinical-stage genetic medicines company, raised over $29M in additional funding.
Backers were undisclosed.
It also reported expanded support from the Cystic Fibrosis Foundation (CF Foundation) an... |
| 13.06.2025 | Signify Bio: $15 Million Raised For Creating Personalized Medicines | Signify Bio, which is a pioneering biotechnology company harnessing the human body for the production of in situ protein therapeutics, announced an oversubscribed $15 million initial financing.
The funding round was led by Actium Group with... |
| 19.11.2024 | ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation | - |
| 18.11.2024 | Recode Therapeutics Secures $15 Million in Funding |
MENLO PARK, CA, Recode announced it has secured $15 million in funding, led by The Cystic Fibrosis Foundation.
>> Click here for more funding data on Recode Therapeutics
>> To export Recode Therapeutics funding data to PDF and ... |
| 26.09.2024 | ReCode Therapeutics Doses First Patient in Phase 1b Clinical Study of RCT2100 for the Treatment of Cystic Fibrosis | - |
| 21.02.2024 | ReCode Therapeutics Announces First Participants Dosed in a Phase 1 Healthy Volunteer Clinical Study of Inhaled mRNA-Based Genetic Medicine, RCT2100, for the Treatment of Cystic Fibrosis | - |
| 16.02.2024 | Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis | - |
| 15.02.2024 | Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis | - |
| 20.10.2023 | Self-driving cars roll out in Houston, Q3 VC funding recap, and more trending innovation news | Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup articles on InnovationMap included a roundup of VC funding from last quarter, finalists name... |
| 17.10.2023 | $5M grant expands entrepreneurship opportunities at UH | A $5 million gift from the Wayne Duddlesten Foundation will establish expanded opportunities for entrepreneurship at the University of Houston, according to an announcement from the college earlier this month.
Known as the Wayne B. Duddlest... |
| 09.10.2023 | New energy institute from UH and Shell will put Houston at the center of innovation | Two years ago, Texas’ failing electrical grid became a global sensation and the state was thrust into the spotlight of the developing energy crisis conversation.
This past year, Russia’s invasion of Ukraine again brought the push for altern... |
| 09.10.2023 | Houston AI SaaS startup secures $5.5M seed funding from Austin VC | A Houston startup that's using artificial intelligence and natural language processing to disrupt the retail automotive industry has raised seed funding.
Konect.ai announced a $5.5 million seed investment from Austin-based Silverton Partner... |
| 05.10.2023 | Houston startup raises nearly $2M to expand logistics SaaS platform | A Houston company that's providing innovative unified scheduling software for the logistics industries has raised additional seed funding.
Houston-based Velostics Inc. raised $1.95 million, the company announced this week. The additional se... |
| 03.10.2023 | Houston hospital lands $10 million grant to launch new neurological lab | Houston Methodist announced that it has received a $10 million gift from the The John M. O’Quinn Foundation to support research into neurological disorders, including Alzheimer’s disease, Parkinson’s disease and others.
The gift will create... |
| 27.09.2023 | Rice researchers score $45M from NIH for cancer-fighting tech | A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.
Rice researchers received $45 million from the National Institutes of Health'... |
| 26.09.2023 | Growing Houston tech nonprofit expands access to textbooks for college students | If everyone that attended a college or university were polled, they’d all likely agree that one of the worst parts of the experience was the rising costs of textbooks.
In an effort to combat the hefty price tag of assigned texts, OpenStax, ... |
| 25.09.2023 | Houston-based, cancer-fighting organization breaks ground on new collaborative building | Houston is where medical researchers and clinicians come together. And it’s getting easier for that to happen thanks to an innovative new facility from The University of Texas MD Anderson Cancer Center.
On September 20, the world-class inst... |
| 21.09.2023 | Houston program buoys promising cancer research with live-saving innovation | How do you bring promising cancer research to the masses? TMC Innovation's Accelerator for Cancer Therapeutics was established with that question in mind.
Funded by a $5 million grant from CPRIT, or the Cancer Prevention and Research Instit... |
| 19.09.2023 | ReCode Therapeutics Raises Additional USD50M in Series B Financing | ReCode Therapeutics, a Menlo Park, CA-based clinical-stage genetic medicines company using precision delivery mRNA and gene correction therapeutics, closed an extension to its Series B financing, raising an additional $50m, for a total of $... |
| 19.09.2023 | ReCode Therapeutics Secures Additional $50M |
MENLO PARK, CA, ReCode Therapeutics today announced the closing of an extension to its Series B financing.
>> Click here for more funding data on ReCode Therapeutics
>> To export ReCode Therapeutics funding data to PDF and E... |
| 15.09.2023 | Rice's new 'moonshot' initiative, VCs on Houston innovation, and more trending news | Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included the a roundup of key moments from Venture Houston, a unique n... |
| 11.09.2023 | 3 Houston innovators to know this week | Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health care to energy tech — recently making headlines in Houston innovation.
Michelle Stansbury, vi... |
| 11.09.2023 | Rice University launches research innovation grant program with VC fund in the works | Over 60 years ago at Rice University, President John F. Kennedy recommitted the country to the Space Race. Now, decades later, the university is announcing its commitment to moonshot innovators.
Rice University's Office of Innovation establ... |
| 08.09.2023 | Houston startup launches networking app for next-generation energy workforce | A Houston-based media organization dedicated to covering the energy industry has officially launched the beta program of their networking app.
After producing zanily named energy podcasts like “Big Digital Energy” and “What the Funk,” Digit... |
| 30.08.2023 | 13 initiatives receive grant funding from new EV-focused, Houston-led program | Evolve Houston awarded its inaugural microgrants this week to 13 groups, neighborhoods and an individual working to make electric vehicles accessible to all Houstonians.
Launched in 2022, Evolve's eMobility Microgrant Initiative supports co... |
| 24.08.2023 | Houston to host 6 Italian aerospace companies with new program | It's an Italian invasion in Houston — and it's happening in the name of accelerating innovation within aerospace.
For the first time, Italy has announced an international aerospace-focused program in the United States. The Italian Trade Age... |
| 30.06.2022 | Modsy, an interior design startup founded by a Google Ventures partner, is shutting down its design business and splitting ties with designers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
As the markets continue to plunge and venture investors pull back, a digital interior design star... |
| 25.10.2021 | Digital health news, funding roundup in the prior week; October 25, 2021 | Biden doubts Medicare benefits expansion; SonderMined acquires predictive analytics platform Qntfy
Highlights from our Q3’21 State Of Healthcare report from CB Insights. The report includes: healthcare startups saw a record 1,904 deals in Q... |
| 22.10.2021 | ReCode Therapeutics picks up $80M | ReCode Therapeutics has raised $80 million in a Series B co-led by Pfizer Ventures and EcoR1 Capital, with support from Superstring Capital, NS Investment, MPM Capital and others. Operating out of California and Texas, the company is creati... |
| 22.10.2021 | Daily funding roundup - October 21, 2021 | Bardavon Health Innovations raised $90M; Jupiter Intelligence landed $54M; Honeycomb secured $50M
Brex: Brex is a San Francisco-based startup that provides credit cards to other startups. Brex just raised $300 million in fresh funding in a ... |
| 22.10.2021 | Is former WeWork CEO Adam Neumann preparing his second act? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Some two years ago, office-sharing company WeWork withdrew its IPO plans after struggling to find... |
| 22.10.2021 | ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million | - |
| 21.10.2021 | ReCode Therapeutics : Raises Oversubscribed Series B Financing Round of $80 Million | ReCode Therapeutics (the “Company”), a biopharmaceutical company pioneering disease-modifying genetic medicines using its proprietary LNP delivery platform, today announced the closing of an $80 million Series B financing round co-led by Pf... |
| 21.10.2021 | ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million | - |
| 30.03.2020 | ReCode Therapeutics Raises $80 Million In Oversubscribed Series A Financing | - |
| 28.03.2020 | ReCode Therapeutics Lands $80M in Series A |
DALLAS, TX, ReCode Therapeutics has closed an oversubscribed $80M Series A financing round. OrbiMed Advisors LLC and Colt Ventures co-led the round.
>> Click here for more funding data on ReCode Therapeutics
>> To export ReC... |
| 26.03.2020 | ReCode Therapeutics nets $80M to push RNA treatment for cystic fibrosis | Over the years, more and more patients with cystic fibrosis have benefited from new drugs such as Vertex’s Trikafta. But there is still a subset of patients with certain mutations for whom those drugs don’t work.
Enter ReCode Therapeutics, ... |
| 26.03.2020 | ReCode Therapeutics nets $80M to push RNA treatment for cystic fibrosis | Over the years, more and more patients with cystic fibrosis have benefited from new drugs such as Vertex’s Trikafta. But there is still a subset of patients with certain mutations for whom those drugs don’t work.
Sponsored by Agilent Techno... |
| - | Blocking FDA approval of abortion pill could stifle innovation in the biopharma industry, experts say | A complicated legal fight over the Food and Drug Administration’s approval of the abortion pill mifepristone could stifle innovation in the biopharma industry.
If courts affirm U.S. District Judge Matthew Kacsmaryk’s decision to suspend the... |
| - | ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs | In genetic medicines, delivery is key. You want to make sure that the medicine reaches its destination in the body and doesn’t cause any problems along the way. But before that, you want to ensure that the chosen delivery vehicle has enough... |
| - | ReCode Therapeutics | “ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized mRNA and gene correction with redosing capability.”... |
